SEARCH HEALTH CONDITIONS BY ALPHABETS
Factor IX Deficiency
Medications for Factor IX Deficiency
Other names: Christmas Illness; Factor IX Hemophilia
About Factor IX Deficiency: Factor IX Deficiency additionally Called Hemophilia B, has been a blood clotting disorder, caused by a congenital deficiency of factor IX.
Drugs Used to Treat Factor IX Deficiency
This list of medications come in some way associated with, or utilized in the treatment of this particular condition.
| Medication name | Rx / OTC | Pregnancy | CSA | Alcohol | Reviews | Rating | Popularity |
|---|---|---|---|---|---|---|---|
| BeneFix | Rx | C | N | 1 inspection | 6.0 | ||
Generic title: coagulation factor ix systemic Medication course: miscellaneous coagulation modifiers For customers: dose, interactions, side effects For professionals: AHFS DI Monograph, Prescribing Information | |||||||
| Cyklokapron | Rx | B | N | 1 inspection | 9.0 | ||
Generic title: tranexamic acid systemic Medication course: miscellaneous coagulation modifiers For customers: dose, interactions, side effects For professionals: Prescribing Information | |||||||
| Profilnine SD | Rx | C | N | Insert inspection | 0.0 | ||
Generic title: variable ix complex systemic Medication course: miscellaneous coagulation modifiers For customers: dose, interactions, side effects For professionals: Prescribing Information | |||||||
| coagulation factor ix | Rx | C | N | 1 inspection | 6.0 | ||
Generic title: coagulation factor ix systemic Brand names: BeneFix, Alphanine SD, Mononine Medication course: miscellaneous coagulation modifiers For customers: dose, interactions, For professionals: a Z Drug Facts, AHFS DI Monograph | |||||||
| tranexamic acid | Rx | B | N | 1 inspection | 9.0 | ||
Generic title: tranexamic acid systemic Brand title: Cyklokapron Medication course: miscellaneous coagulation modifiers For customers: dose, interactions, For professionals: a Z Drug Facts, Prescribing Information | |||||||
| Alphanine SD | Rx | C | N | Insert inspection | 0.0 | ||
Generic title: coagulation factor ix systemic Medication course: miscellaneous coagulation modifiers For customers: dose, interactions, side effects For professionals: Prescribing Information | |||||||
| variable ix complicated | Rx | C | N | Insert inspection | 0.0 | ||
Generic title: variable ix complex systemic Brand names: Profilnine SD, Bebulin Medication course: miscellaneous coagulation modifiers For customers: dose, interactions, For professionals: a Z Drug Facts | |||||||
| Mononine | Rx | C | N | Insert inspection | 0.0 | ||
Generic title: coagulation factor ix systemic Medication course: miscellaneous coagulation modifiers For customers: dose, interactions, side effects For professionals: Prescribing Information | |||||||
| Bebulin | Rx | C | N | Insert inspection | 0.0 | ||
Generic title: variable ix complex systemic For users: dose, interactions, negative effects | |||||||
Legend
| Rx | Prescription Only |
|---|---|
| OTC | Over the Counter |
| Rx/OTC | Prescription or Over The Counter |
| Away Prizes | This medication might not be accepted by the FDA for the treatment of the particular condition. |
| Pregnancy Category | |
|---|---|
| A | Adequate and well-controlled studies have failed to demonstrate a risk to the embryo within the first trimester of pregnancy (and there isn`t any evidence of risk in later trimesters). |
| B | Animal reproduction studies have failed to demonstrate a risk to the fetus and there are no adequate and well-controlled studies in pregnant women. |
| C | Animal research studies have shown an adverse effect in the fetus and there are no adequate and well-controlled studies in humans, but possible benefits may warrant used in pregnant women despite potential risks. |
| D | There is positive evidence of human fetal risk based on adverse reaction data from investigational or marketing experience or studies in humans, but possible benefits may justify used in pregnant women despite potential risks. |
| X | Studies in animals or humans have demonstrated fetal abnormalities and/or there`s positive evidence of human fetal risk based on adverse reaction data from investigational or marketing experience, and also the risks involved in used in pregnant women clearly outweigh potential benefits. |
| N | FDA have not classified the medication. |
| Controlled Substances Act (CSA) Schedule | |
|---|---|
| N | Is not at the mercy of the Controlled Substances Act. |
| 1 | Has a higher potential for abuse. Has no accepted medical use in treatment in the USA. There is just a lack of accepted safety for use under medical supervision. |
| 2 | Has a higher potential for abuse. Features a currently accepted medical use with severe restrictions or a currently accepted medical use in treatment in the USA. Psychotherapy can result in severe physical or emotional dependency. |
| 3 | Has a possibility for abuse less than individuals in schedules 1 and two. Features a currently accepted medical use in treatment in the USA. Psychotherapy can lead to moderate or low physical dependence or high psychological dependence. |
| 4 | Has a very low potential for abuse in accordance with individuals in program 3. It has a currently accepted medical use in treatment in the USA. Psychotherapy can lead to limited physical dependence or psychological dependence. |
| 5 | Has a very low potential for abuse in accordance with individuals in program 4. Features a currently accepted medical use in treatment in the USA. Psychotherapy can lead to limited physical dependence or psychological dependence. |
| Alcohol | |
|---|---|
| X | Interacts with Medication. |
Browse Treatment Plans
- A
- B
- C
- D
- E
- F
- G
- H
- I
- J
- K
- L
- M
- N
- O
- P
- Q
- Ep
- S
- T
- U
- V
- W
- X
- Y
- Z
Further advice
Always seek advice from your physician to make sure the information applies to your circumstances.
Top USA Pharma Companies
Popular Categories
Easily find an affordable health insurance plan
